MX2014007437A - Procedimiento de deteccion de una infeccion por el virus de la hepatitis c. - Google Patents

Procedimiento de deteccion de una infeccion por el virus de la hepatitis c.

Info

Publication number
MX2014007437A
MX2014007437A MX2014007437A MX2014007437A MX2014007437A MX 2014007437 A MX2014007437 A MX 2014007437A MX 2014007437 A MX2014007437 A MX 2014007437A MX 2014007437 A MX2014007437 A MX 2014007437A MX 2014007437 A MX2014007437 A MX 2014007437A
Authority
MX
Mexico
Prior art keywords
capsid
hepatitis
virus
infection
peptide
Prior art date
Application number
MX2014007437A
Other languages
English (en)
Other versions
MX365962B (es
Inventor
Stéphane Gadelle
François Rieunier
Original Assignee
Bio Rad Innovations
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Innovations filed Critical Bio Rad Innovations
Publication of MX2014007437A publication Critical patent/MX2014007437A/es
Publication of MX365962B publication Critical patent/MX365962B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G01N2333/183—Flaviviridae, e.g. pestivirus, mucosal disease virus, bovine viral diarrhoea virus, classical swine fever virus (hog cholera virus) or border disease virus
    • G01N2333/186—Hepatitis C; Hepatitis NANB
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La invención se refiere a un procedimiento de detección in vitro de una infección por un virus de la hepatitis C (VHC) en una muestra biológica, que comprende la detección simultánea de la proteína de cápside de VHC, y de un anticuerpo dirigido contra la citada proteína de cápside, que este procedimiento utiliza, para capturar los anticuerpos anticápside, que un péptido comprende un fragmento antigénico derivado de la cápside de VHC truncada. La invención se refiere también al péptido para capturar los anticuerpos anticápside y los kits que los comprenden.
MX2014007437A 2011-12-20 2012-12-19 Procedimiento de detección de una infección por el virus de la hepatitis c. MX365962B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1161981A FR2984328B1 (fr) 2011-12-20 2011-12-20 Procede de detection d'une infection par le virus de l'hepatite c
PCT/FR2012/053001 WO2013093345A1 (fr) 2011-12-20 2012-12-19 Procede de detection d'une infection par le virus de l'hepatite c

Publications (2)

Publication Number Publication Date
MX2014007437A true MX2014007437A (es) 2015-03-03
MX365962B MX365962B (es) 2018-05-04

Family

ID=47599082

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014007437A MX365962B (es) 2011-12-20 2012-12-19 Procedimiento de detección de una infección por el virus de la hepatitis c.

Country Status (12)

Country Link
US (2) US9719994B2 (es)
EP (1) EP2794638B1 (es)
JP (1) JP6312600B2 (es)
CN (1) CN104302660B (es)
AR (1) AR089335A1 (es)
AU (1) AU2012356512B2 (es)
BR (1) BR112014015201A2 (es)
CA (1) CA2859736C (es)
FR (1) FR2984328B1 (es)
MX (1) MX365962B (es)
TW (1) TW201337268A (es)
WO (1) WO2013093345A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110261616B (zh) * 2019-04-30 2021-07-20 广东菲鹏生物有限公司 一种丙型肝炎病毒检测试剂盒
CN113419061B (zh) * 2020-06-19 2022-02-01 南京金斯瑞生物科技有限公司 检测SARS-CoV-2病毒中和抗体的磁微粒化学发光试剂盒及其应用
WO2023207918A1 (en) * 2022-04-25 2023-11-02 Beijing Hanmoluojie Technology Co., Ltd. Aav capsid 3d molecular surface feature mapping

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5693489A (en) 1984-03-30 1997-12-02 Associated Universities, Inc. Cloning and expression of the gene for bacteriophage T7 RNA polymerase
CA1340522C (en) 1987-03-10 1999-05-04 Heinz Dobeli Fusion proteins containing neighbouring histidines for improved purification
US5683864A (en) 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US6027729A (en) 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
JP2733138B2 (ja) 1990-04-04 1998-03-30 カイロン コーポレイション 抗ｈｃｖ抗体の免疫アッセイに使用するｃ型肝炎ウイルス（ｈｃｖ）抗原の組合せ
US5712087A (en) 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
DE69232871T2 (de) 1991-06-24 2003-05-08 Chiron Corp Polypeptide des hepatitis c-virus (hiv)
DE4209215A1 (de) 1991-07-04 1993-01-07 Boehringer Mannheim Gmbh Hcv peptidantigene und verfahren zur bestimmung von hcv
DE69232859T2 (de) 1991-09-13 2003-04-10 Chiron Corp Zusammensetzung aus mehreren immunreaktiven hepatitis-c-virus-polypeptiden
BR9305435A (pt) 1992-03-06 1994-12-27 Innogenetics Nv Processo para determinação de peptídeos correspondendo a epítopos imunologicamente importantes e seu uso em um processo para determinação de anticorpos ou peptídeos biotinilados correspondendo a epítopos imunologicamente importantes, processo para preparação dos mesmos e composições contendo os mesmos
FR2690921B1 (fr) 1992-05-06 1995-06-30 Bio Merieux Polypeptides de synthese appartenant au virus de l'hepatite c (vhc) et utilisables notamment pour detecter ce dernier.
UA39944C2 (uk) 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
DE69434117T3 (de) 1993-05-10 2009-10-08 Novartis Vaccines and Diagnostics, Inc.(n.d.Ges.d.Staates Delaware), Emeryville Verfahren zur typisierung von hepatitis c viren und dafür zu verwendende reagenzien
DE69433160T2 (de) 1993-05-12 2004-07-08 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Konserviertes Motiv der Hepatitis C Virus E2/NS1 Region
JP3217600B2 (ja) 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
CA2195312A1 (en) 1994-07-29 1996-02-15 Mark Selby Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same
DE4428705A1 (de) 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
DK0752102T3 (da) 1995-01-23 2001-01-08 Pasteur Sanofi Diagnostics Immunoenzymatisk konjugat, fremgangsmåde til fremstilling af konjugatet og anvendelse af dette.
US5672662A (en) 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
JP3715027B2 (ja) 1996-05-07 2005-11-09 シスメックス株式会社 Ｃ型肝炎ウイルス感染症診断薬
EP0870830A3 (en) 1997-02-10 2004-02-25 Advanced Life Science Institute, Inc. Chimera hepatitis C virus antigen
CN1207569C (zh) 1997-08-04 2005-06-22 株式会社先端生命科学研究所 用于测定含病毒样品的方法、病毒测定方法和诊断试剂盒
CA2493240A1 (en) 1997-08-04 1999-02-11 Advanced Life Science Institute, Inc. Methods for detecting or assaying virus
CA2607990C (en) 1997-08-04 2009-09-22 Advanced Life Science Institute, Inc. Methods for detecting or assaying virus
PT1071955E (pt) 1998-04-17 2005-02-28 Innogenetics Nv Ensaios melhorados de diagnostico imunologico utilizando agentes redutores
US6623921B2 (en) 1998-07-30 2003-09-23 Advanced Life Science Institute, Inc. Method for measurement of hepatitis C virus
BR9906660A (pt) 1998-07-30 2000-08-29 Advanced Life Science Inst Inc Processo para medir vìrus da hepatite c
WO2000031130A1 (en) * 1998-11-20 2000-06-02 Bio Merieux Synthetic polypeptides corresponding to the hepatitis c virus (hcv) and applications
JP5498637B2 (ja) 1999-07-28 2014-05-21 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド Ｃ型肝炎ウイルス抗原免疫アッセイ検出システム
US6815160B1 (en) 1999-07-28 2004-11-09 Chiron Corporation Hepatitis C viral antigen immunoassay detection systems
AU2001272945A1 (en) 2000-06-15 2001-12-24 Chiron Corporation Immunoassays for anti-hcv antibodies
SG118120A1 (en) 2001-03-28 2006-01-27 Ortho Clinical Diagnostics Inc A hepatitis C antigen - antibody combination assayfor the early detection of HCV infection
US7101683B2 (en) 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies
EP1412538B1 (en) 2001-06-26 2013-03-27 Abbott Laboratories Methods for the simultaneous detection of hcv antigens and hcv antibodies
US7049060B2 (en) 2001-11-05 2006-05-23 Ortho-Clinical Diagnostics, Inc. HCV anti-core monoclonal antibodies
US20030108563A1 (en) * 2001-11-07 2003-06-12 Chander Bahl Reagents for the simultaneous detection of HCV core antigens and antibodies
US7332269B2 (en) 2001-11-11 2008-02-19 Ortho-Clinical Diagnostics, Inc. HCV core protein sequences
FR2839555B1 (fr) * 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
EP1546414B1 (en) 2002-09-09 2008-10-08 Novartis Vaccines and Diagnostics, Inc. Hcv assay
US8865398B2 (en) 2006-09-01 2014-10-21 Abbott Laboratories Combination hepatitis C virus antigen and antibody detection method
US7858752B2 (en) * 2006-12-05 2010-12-28 Abbott Laboratories Recombinant antibodies against hepatitis C virus and methods of obtaining and using same
CN102378914B (zh) * 2009-03-30 2014-12-10 生物梅里埃公司 用于hcv检测的固体支持物
US20100297607A1 (en) 2009-05-20 2010-11-25 Jian Zheng Reagents For HCV Antigen-Antibody Combination Assays
CN102081018A (zh) 2009-11-30 2011-06-01 希森美康株式会社 样品的预处理方法及hcv的免疫测定方法

Also Published As

Publication number Publication date
US20140335508A1 (en) 2014-11-13
AU2012356512A1 (en) 2014-07-24
MX365962B (es) 2018-05-04
AU2012356512B2 (en) 2017-07-20
JP2015502552A (ja) 2015-01-22
AR089335A1 (es) 2014-08-13
JP6312600B2 (ja) 2018-04-18
CA2859736C (fr) 2021-03-30
CA2859736A1 (fr) 2013-06-27
US10345305B2 (en) 2019-07-09
WO2013093345A1 (fr) 2013-06-27
EP2794638B1 (fr) 2020-05-27
EP2794638A1 (fr) 2014-10-29
FR2984328A1 (fr) 2013-06-21
FR2984328B1 (fr) 2016-12-30
CN104302660A (zh) 2015-01-21
US9719994B2 (en) 2017-08-01
CN104302660B (zh) 2018-04-20
BR112014015201A2 (pt) 2019-09-24
TW201337268A (zh) 2013-09-16
US20170328905A1 (en) 2017-11-16

Similar Documents

Publication Publication Date Title
MX2019001767A (es) Anticuerpos monoclonales que se unen al dominio de union a lipidos de la proteina de la capside del virus de la hepatitis c (vhc).
WO2008027942A3 (en) Combination hepatitis c virus antigen and antibody detection method
SG11201810029PA (en) Immunochromatography Analysis Device for Detecting Zika Virus
EA201492110A1 (ru) Вакцины против впг-2
MX2009005942A (es) Anticuerpos recombinantes contra el virus de hepatitis c y metodos para obtener y usar los mismos.
EP2641914A4 (en) MONOCLONAL ANTIBODY FOR THE RECOGNITION OF HUMAN PAPILLOMA (HPV) PROTEIN L2 AND METHOD FOR MEASURING HPV NEUTRALIZING ANTIBODIES THEREWITH
WO2014134561A3 (en) Quantification of vaccine compositions
CL2013003248A1 (es) Composición inmunogenica que comprende una glucoproteina g de los virus hendra y nipah y un complejo inmunoestimulante; método para producir una respuesta de anticuerpo neutralizante contra un virus hendra y/o nipah en un sujeto.
EA201390806A1 (ru) Конструкция пептидного каркаса
MX2015012824A (es) Antigenos recombinantes ns3 del vhc y mutantes de los mismos para la deteccion mejorada de anticuerpos.
MX354822B (es) Metodos para la deteccion de anticuerpos neutralizantes anticitomegalovirus.
WO2009035412A8 (en) Monoclonal antibodies specific to hemagglutinin from influenza virus h5-subtype and uses thereof
EA201071086A1 (ru) Усовершенствованный способ получения вакцинных антигенов вируса гриппа
MX2016005686A (es) Ensayo de union competitiva al ligando para detectar anticuerpos neutralizantes.
WO2015196192A3 (en) Methods and compositions relating to dengue virus
WO2015112558A3 (en) Peptides, devices, and methods for the detection of anaplasma antibodies
MX365962B (es) Procedimiento de detección de una infección por el virus de la hepatitis c.
EA202191931A1 (ru) Способ характеризации видимых и/или невидимых частиц в биологических препаратах
WO2007108568A8 (en) Hn epitope recognized by avian immune system and antigenic variant newcastle disease viruses carrying changes in the epitope
WO2016069762A3 (en) Subject anti-hcv antibody detection assays employing ns3 capture peptides
WO2007020520A3 (en) Antigenic peptides and their use
EA201991843A1 (ru) Способ иммунологического определения специфических антител к антигенам вирусов семейства поксвирусов
TW200722527A (en) Methods of detecting hepatitis C virus
WO2012114312A3 (en) Exogenous internal positive control
WO2011041788A3 (en) Turkey viral hepatitis virus and uses thereof

Legal Events

Date Code Title Description
FG Grant or registration